- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- 2025-07-02, 21:47:15
- Local Time:
- 2025-07-05, 06:20:43
- Last Active:
- 2025-07-03, 00:24:18
Signature:
Our findings also highlight the therapeutic value of inhibiting ALOX5 in breast cancer, particularly those patients with the HER2 overexpression.-D